| 2 |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2019概要 [J]. 中国循环杂志, 2020, 35(9): 833-854.
|
| 3 |
D'Arcy JL, Coffey S, Loudon MA, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study [J]. Eur Heart J, 2016, 37(47): 3515-3522.
|
| 4 |
Thanassoulis G, Campbell CY, Owens DS, et al. Genetic associations with valvular calcification and aortic stenosis [J]. N Engl J Med, 2013, 368(6): 503-512.
|
| 5 |
Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. the Tromsø Study [J]. Heart, 2013, 99(6): 396-400.
|
| 6 |
Rao C, Zhang H, Gao H, et al. The Chinese cardiac surgery registry: design and data audit [J]. Ann Thorac Surg, 2016, 101(4): 1514-1520.
|
| 7 |
Liu FZ, Xue YM, Liao HT, et al. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China [J]. J Thorac Dis, 2014, 6(12): 1724-1730.
|
| 8 |
Hu P, Liu XB, Liang J, et al. A hospital-based survey of patients with severe valvular heart disease in China [J]. Int J Cardiol, 2017, 231: 244-247.
|
| 9 |
Ferreira-González I, Pinar-Sopena J, Ribera A, et al. Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area [J]. Eur J Prev Cardiol, 2013, 20(6): 1022-1030.
|
| 10 |
Passmore M, Nataatmadja M, Fung YL, et al. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation [J]. Eur J Cardiothoracic Surg, 2015, 48(3): e20-e29.
|
| 11 |
Capoulade R, Chan KL, Yeang C, et al. Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis [J]. J Am Coll Cardiol, 2015, 66(11): 1236-1246.
|
| 12 |
Steiner I, Krbal L, Dominik J. Blood vessels and lymphatics in calcific aortic stenosis-in support of its inflammatory pathogenesis [J]. Cesk Patol, 2010, 46(2): 33-36.
|
| 13 |
Jung JJ, Razavian M, Challa AA, et al. Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease [J]. J Nucl Med, 2015, 56(6): 933-938.
|
| 14 |
Jung JJ, Razavian M, Kim HY, et al. Matrix metalloproteinase inhibitor, doxycycline and progression of calcific aortic valve disease in hyperlipidemic mice [J]. Sci Rep, 2016, 6: 32659.
|
| 15 |
Yildirir A. Valvular heart disease associated with coronary artery disease [J]. Anadolu Kardiyol Derg, 2009, Suppl 1: 10-16.
|
| 16 |
Chetboul V, Tissier R. Echocardiographic assessment of canine degenerative mitral valve disease [J]. J Vet Cardiol, 2012, 14(1): 127-148.
|
| 17 |
吴静, 龚亚驰, 龚念梅, 等. 超声心动图在老年退行性心瓣膜病中的应用价值 [J]. 中国老年学杂志, 2015, 35(13): 3574-3575.
|
| 18 |
李康, 杨重庆, 张瑞生, 等. 经胸超声心动图对老年患者左心瓣膜钙化诊断的准确性评价 [J]. 中华老年医学杂志, 2017, 36(4): 395-399.
|
| 19 |
钱蕴秋. 超声诊断学 [M]. 2版. 西安: 第四军医大学出版社, 2008.
|
| 20 |
Baumgartner H, Hung J, Bermejo J, et al. Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography [J]. J Am Soc Echocardiogr, 2017, 30(4): 372-392.
|
| 21 |
Rong LQ, Hameed I, Salemi A, et al. Three-dimensional echocardiography for transcatheter aortic valve replacement sizing: a systematic review and meta‐analysis [J]. J Am Heart Assoc, 2019, 8(19): e013463.
|
| 22 |
袁媛, 马小静, 韩敏, 等. 老年退行性心脏瓣膜病经胸超声心动图诊断及发病影响因素分析 [J/CD]. 中华临床医师杂志(电子版), 2013, 7(10): 4549-4551.
|
| 23 |
Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance [J]. J Am Soc Echocardiogr, 2017, 30(4): 303-371.
|
| 24 |
Otto C, Bonow R. Valvular heart disease [M]. Philadelphia: Elsevier Saunders, 2014: 70.
|
| 25 |
Chu JW, Levine RA, Chua S, et al. Assessing mitral valve area and orifice geometry in calcific mitral stenosis: a new solution by real-time three-dimensional echocardiography [J]. J Am Soc Echocardiogr, 2008, 21(9): 1006-1009.
|
| 26 |
Anwar AM, Attia WM, Nosir YFM, et al. Validation of a new score for the assessment of mitral stenosis using real-time three-dimensional echocardiography [J]. J Am Soc Echocardiogr, 2010, 23(1): 13-22.
|
| 27 |
Pressman GS, Ran JR, Park DH, et al. Degenerative mitral stenosis versus rheumatic mitral stenosis [J]. Am J Cardiol, 2020, 125(10): 1536-1542.
|
| 28 |
Mihaila S, Muraru D, Miglioranza MH, et al. Relationship between mitral annulus function and mitral regurgitation severity and left atrial remodelling in patients with primary mitral regurgitation [J]. Eur Heart J Cardiovasc Imaging, 2016, 17(8): 918-929.
|
| 29 |
Wunderlich NC, Beigel R, Rader F, et al. Degenerative mitral regurgitation: assessment, physical examination and imaging [J]. Curr Cardiol Rep, 2019, 21(8): 85.
|
| 30 |
Addetia K, Mor-Avi V, Weinert L, et al. A new definition for an old entity: improved definition of mitral valve prolapse using three-dimensional echocardiography and color-coded parametric models [J]. J Am Soc Echocardiogr, 2014, 27(1): 8-16.
|
| 31 |
Soulat-Dufour L, Addetia K. Degenerative mitral regurgitation [J]. Curr Opin in Cardiol, 2020, 35(5): 454-463.
|
| 32 |
Heo R, Son JW, Hartaigh Bó, et al. Clinical implications of three-dimensional real-time color doppler transthoracic echocardiography in quantifying mitral regurgitation: a comparison with conventional two-dimensional methods [J]. J Am Soc Echocardiogr, 2017, 30(4): 393-403.e7.
|
| 33 |
Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult [J]. Nat Rev Cardiol, 2011, 8(3): 162-172.
|
| 34 |
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideling for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [J]. J Am Coll Cardiol, 2014, 63(22): 2438-2488.
|
| 35 |
Meester C, Gerber BL, Vancraeynest D, et al. Early surgical intervention versus watchful waiting and outcomes for asymptomatic severe aortic regurgitation [J]. J Thorac Cardiovasc Surg, 2015, 150(5): 1100-1108.
|
| 1 |
D'Arcy JL, Prendergast BD, Chambers JB, et al. Valvular heart disease: the next cardiac epidemic [J]. Heart, 2011, 97(2): 91-93.
|
| 36 |
Otto CM, Prendergast B. Aortic-valve stenosis - from patients at risk to severe valve obstruction [J]. N Engl J Med, 2014, 371(8): 744-756.
|
| 37 |
Ramaraj R, Sorrell VL. Degenerative aortic stenosis [J]. BMJ, 2008, 336(7643): 550-555.
|